FINANCIAL INSTRUMENTS (Tables)

3 Months Ended

Mar. 31, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The following table presents the classification of the Company’s financial instruments that are required to be measured at fair value on a recurring basis on the Company’s Condensed Consolidated Balance Sheets (in thousands):

	March 31, 2024		December 31, 2023
Current assets:
Natural gas financial instruments	$	—	$	—
Current liabilities:
Embedded derivatives	7,183		13,332
Long-term liabilities:
Embedded derivatives	11,329		18,892

Schedule of Derivative Instruments, Gain (Loss)

The following table summarizes the effect of the Company’s financial instruments on the Condensed Consolidated Statements of Operations (in thousands):

	Three Months Ended March 31,
	2024		2023
Natural gas financial instruments:
Realized gain	$	—	$	11,866
Unrealized loss	—		428
Contingent Consideration:
Realized gain	—		118
Embedded Derivatives
Realized loss	2,145		—
Unrealized loss	1,959		—

Schedule of Derivative Instruments

The following table summarizes changes in the Company’s Embedded Derivatives (in thousands):

	Three Months Ended March 31, 2024
Balance at January 1, 2024	$	32,225
Issued	—
Settled	(17,817)
Total gains or losses (realized and unrealized) included in earnings	4,103
Balance at March 31, 2024	$	18,511